ClinicalTrials.gov Identifier ClinicalTrials.gov Identifier Interventions Mechanism of action Status (Phase)
NCT04283461 mRNA-1273 mRNA-1273 Novel lipid nanoparticle (LNP)-encapsulated mRNA-based vaccine that encodes for a full-length, spike (S) protein I
NCT04313127 Ad5-nCoV Ad5-nCoV Adenovirus type 5 vector that expresses S protein I
NCT04336410 NO-4800 NO-4800 DNA plasmid encoding S protein delivered by electroporation I
NCT04276896 LV-SMENP-DC LV-SMENP-DC Lentiviral vector system (NHP/TYF) expressing viral proteins and immune modulatory genes to modify dendritic cells (DCs) and to activate T cells II
NCT04299724 Pathogen-specific aAPC Pathogen-specific aAPC aAPCs modified with lentiviral vector expressing synthetic minigene based on domains of selected viral proteins I